The ECDC, the infectious diseases watchdog, has asked for scientists to join its new panel on RSV as Europe begins to vaccinate its most vulnerable adults.

Booster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research, led by the ...

Booster vaccines reduced the risk of COVID‑19–related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research led by the ...

Pfizer PFE1.65%increase; green up pointing triangle reported lower fourth-quarter sales as demand for its Covid-19 vaccine and antiviral drug continued to decline. The drugmaker reported a loss of ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual property developed by Monsanto, the crop science company the German company ...

The Centers for Disease Control and Prevention has issued updated guidance on who should receive the 2025 COVID-19 booster, focusing on people most at risk for severe illness. Under the current ...

Adrian Esterman receives funding from the NHMRC, MRFF and ARC. COVID rarely rates a mention in the news these days, yet it hasn’t gone away. SARS-CoV-2, the virus that causes COVID, is still with us.

The Food and Drug Administration (FDA) is investigating whether the COVID-19 vaccines were associated with any deaths across all age ranges. “FDA is doing a thorough investigation, across multiple age ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering immune responses and sustaining protection, according to an analysis ...

Two years ago, Pfizer anticipated that sales of its rebound-prone COVID-19 oral antiviral Paxlovid and fully approved mRNA COVID vaccine Comirnaty would plummet, but good news appeared on the horizon: ...